Troglitazone (Rezulin, Resulin, Romozin, Noscal) is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones.
Rezulin (troglitazone) is an oral antihyperglycemic agent which acts primarily by decreasing insulin resistance. Rezulin (troglitazone removed from the us market 3/21 ...
Troglitazone has been withdrawn from the U.S. market. Troglitazone is an antihyperglycemic agent. It helps your body respond better to insulin and it reduces the ...
Introduction Troglitazone was the first thiazolidinedione approved for use in the United States and was licensed for use in type 2 diabetes in 1997, but ...
Troglitazone: Webster's Timeline History, 1994 - 2007 [Icon Group International] on Amazon.com. *FREE* shipping on qualifying offers. Webster's bibliographic and ...
View and buy high purity Troglitazone from Tocris Bioscience, the leading worldwide supplier of high performance life science reagents
Troglitazone, LY294002 and an insulin sensitizer have been used for treatment of nutrient deprivation and have been demonstrated to kill cancer cells only under ...
Troglitazone was the first thiazolidinedione antidiabetic agent approved for clinical use in 1997, but it was withdrawn from the market in 2000 due to serious ...
Lists the various brand names available for medicines containing troglitazone. Find information on troglitazone use, treatment, drug class and molecular formula.
Rezulin (troglitazone) Parke-Davis/Warner Lambert agree to FDA's request to withdraw Rezulin from the market. FDA asked Parke-Davis/Warner Lambert to withdraw Rezulin ...